|
April. 20, 2009 |
|
|
Dec. 17, 2018 |
|
|
jRCT2080220721 |
Phase II Study of 0.15% UF-021 in patients with retinitis pigmentosa |
|
Phase II Study of 0.15% UF-021 in patients with retinitis pigmentosa |
| version: date: |
R-tech Ueno, Ltd |
||
http://www.rtechueno.com/contact_jp.php |
||
| 105 | ||
Interventional |
||
Multicenter, randomized, double-blind, parallel-three groups study |
||
2 |
||
Decimal visual acuity: 0.5 or better |
||
The subject has taken steroids and/or vasodilators within 1 month prior to informed consent. |
||
| 20age old over | ||
| 65age old under | ||
Both |
||
retinitis pigmentosa |
||
investigational material(s) |
||
Efficacy and safety |
||
| R-Tech Ueno, Ltd | |
| JapicCTI-090748 | |